A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody
Clinical trial NCT07445815 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07445815
- Sponsor
- Lanzhou Institute of Biological Products Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-31
- Primary completion
- 2026-07-29
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.